TEAM Technologies Joins Arlington's Portfolio in Strategic Acquisition
Deal News | Nov 25, 2024 | Arlington Capital Partners
Arlington Capital Partners, a private investment firm specializing in government-regulated industries, has announced its acquisition of TEAM Technologies, Inc. from Clearlake Capital Group. TEAM Technologies stands as a prominent global manufacturer focusing on medical devices and pharmaceutical supply chains. Known for its advanced vertically integrated processes, the company services top medical and pharmaceutical OEMs. Arlington plans to build upon TEAM Technologies' existing strengths to expand capabilities and customer base. The strategic acquisition aligns with Arlington’s track record in fortifying businesses within highly regulated sectors such as healthcare. The transaction underscores the imperative for secure, robust supply chains in medical manufacturing, amplified by recent challenges within global logistics. Harris Williams served as a financial advisor with Goodwin Procter LLP as legal advisor to Arlington, while R.W. Baird acted as TEAM Technologies' financial counsel with legal support from Kirkland & Ellis LLP and Massumi + Consoli.
Sectors
- Private Equity
- Medical Device Manufacturing
- Healthcare
Geography
- United States – Arlington Capital Partners is based in Washington, D.C., and TEAM Technologies has its headquarters in Morristown, TN.
- Mexico and Singapore – TEAM Technologies has manufacturing spaces in these countries, indicating the geographic operational span beyond the U.S.
Industry
- Private Equity – Arlington Capital Partners, a private investment firm, is the key player in the acquisition.
- Medical Device Manufacturing – TEAM Technologies is a significant entity in the manufacturing of medical devices, focusing on optimizing supply chains.
- Healthcare – The focus on healthcare OEMs and the objective to improve healthcare delivery systems ties this industry closely to the article.
Financials
- $3.8 billion – The fund size that Arlington is currently investing out of, Fund VI.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Arlington Capital Partners | Acquirer | Company | A private investment firm based in Washington, D.C., focusing on government-regulated sectors. |
| TEAM Technologies, Inc. | Target Company | Company | A global manufacturer specializing in advanced medical devices, providing comprehensive manufacturing services. |
| Clearlake Capital Group | Vendor | Company | The selling private equity firm involved in the transaction. |
| Harris Williams | Financial Advisor | Company | Provided financial advisory services to Arlington Capital Partners. |
| Goodwin Procter LLP | Legal Advisor | Company | Legal advisor to Arlington Capital Partners for the acquisition. |
| R.W. Baird | Financial Advisor | Company | Provided financial advisory services to TEAM Technologies. |
| Kirkland & Ellis LLP | Legal Advisor | Company | Provided legal counsel to TEAM Technologies and Clearlake. |
| Massumi + Consoli LLP | Legal Advisor | Company | Provided legal counsel to TEAM Technologies. |